BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yamamoto N, Tsuchiya H. Chemotherapy for osteosarcoma – Where does it come from? What is it? Where is it going? Expert Opinion on Pharmacotherapy 2013;14:2183-93. [DOI: 10.1517/14656566.2013.827171] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Gorska M, Kuban-Jankowska A, Zmijewski MA, Gorzynik M, Szkatula M, Wozniak M. Neuronal nitric oxide synthase induction in the antitumorigenic and neurotoxic effects of 2-methoxyestradiol. Molecules 2014;19:13267-81. [PMID: 25170949 DOI: 10.3390/molecules190913267] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
2 Hamed Kassem Abdelaal A, Yamamoto N, Hayashi K, Takeuchi A, Miwa S, Tsuchiya H. Epiphyseal Sparing and Reconstruction by Frozen Bone Autograft after Malignant Bone Tumor Resection in Children. Sarcoma 2015;2015:892141. [PMID: 27034614 DOI: 10.1155/2015/892141] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
3 Chen D, Hu C, Wen G, Yang Q, Zhang C, Yang H. DownRegulated SOX4 Expression Suppresses Cell Proliferation, Migration, and Induces Apoptosis in Osteosarcoma In Vitro and In Vivo. Calcif Tissue Int 2018;102:117-27. [DOI: 10.1007/s00223-017-0340-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li CJ, Liu XZ, Zhang L, Chen LB, Shi X, Wu SJ, Zhao JN. Advances in Bone-targeted Drug Delivery Systems for Neoadjuvant Chemotherapy for Osteosarcoma. Orthop Surg 2016;8:105-10. [PMID: 27384718 DOI: 10.1111/os.12238] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
5 Yu Q, Li D, Wang D, Hu C, Sun Y, Tang Y, Shi G. Effect of RAB31 silencing on osteosarcoma cell proliferation and migration through the Hedgehog signaling pathway. J Bone Miner Metab 2019;37:594-606. [DOI: 10.1007/s00774-018-0961-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cheng A, Zhang Y, Mei H, Fang S, Ji P, Yang J, Yu L, Guo W. Construction of recombinant pEGFP-N1-hPer2 plasmid and its expression in osteosarcoma cells. Oncol Lett 2016;11:2768-72. [PMID: 27073550 DOI: 10.3892/ol.2016.4291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Igarashi K, Yamamoto N, Shirai T, Hayashi K, Nishida H, Kimura H, Takeuchi A, Tsuchiya H. The long-term outcome following the use of frozen autograft treated with liquid nitrogen in the management of bone and soft-tissue sarcomas. The Bone & Joint Journal 2014;96-B:555-61. [DOI: 10.1302/0301-620x.96b4.32629] [Cited by in Crossref: 50] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
8 Dong Y, Wu W, Kang H, Xiong W, Ye D, Fang Z, Guan H, Liao H, Li F. Risk factors of regional lymph node (RLN) metastasis among patients with bone sarcoma and survival of patients with RLN-positive bone sarcoma. Ann Transl Med 2021;9:48. [PMID: 33553341 DOI: 10.21037/atm-20-4681] [Reference Citation Analysis]
9 Zhang Q, Nettleship I, Schmelzer E, Gerlach J, Zhang X, Wang J, Liu C. Tissue Engineering and Regenerative Medicine Therapies for Cell Senescence in Bone and Cartilage. Tissue Engineering Part B: Reviews 2020;26:64-78. [DOI: 10.1089/ten.teb.2019.0215] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Zou Y, Yang J, Jiang D. Resveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells. Mol Med Rep 2015;12:7221-6. [PMID: 26398440 DOI: 10.3892/mmr.2015.4338] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
11 Mori Y, Terauchi R, Shirai T, Tsuchida S, Mizoshiri N, Arai Y, Kishida T, Fujiwara H, Mazda O, Kubo T. Suppression of heat shock protein 70 by siRNA enhances the antitumor effects of cisplatin in cultured human osteosarcoma cells. Cell Stress Chaperones 2017;22:699-706. [PMID: 28466152 DOI: 10.1007/s12192-017-0793-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
12 Wang JY, Wu PK, Chen PC, Lee CW, Chen WM, Hung SC. Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells. Stem Cells Transl Med 2017;6:512-26. [PMID: 28191765 DOI: 10.5966/sctm.2015-0226] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
13 Gatti M, Solari A, Pattarozzi A, Campanella C, Thellung S, Maniscalco L, De Maria R, Würth R, Corsaro A, Bajetto A, Ratto A, Ferrari A, Daga A, Barbieri F, Florio T. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity. Exp Cell Res 2018;363:48-64. [PMID: 29305964 DOI: 10.1016/j.yexcr.2018.01.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
14 Dai P, He Y, Luo G, Deng J, Jiang N, Fang T, Li Y, Cheng Y. Screening candidate microRNA-mRNA network for predicting the response to chemoresistance in osteosarcoma by bioinformatics analysis. J Cell Biochem 2019;120:16798-810. [PMID: 31090103 DOI: 10.1002/jcb.28938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Niu J, Yan T, Guo W, Wang W, Zhao Z. Insight Into the Role of Autophagy in Osteosarcoma and Its Therapeutic Implication. Front Oncol 2019;9:1232. [PMID: 31803616 DOI: 10.3389/fonc.2019.01232] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
16 Yu H, Qu G, Wang Y, Mai W, Bao JJ, Song C, Yao M. The expression of Eps15 homology domain 1 is negatively correlated with disease-free survival and overall survival of osteosarcoma patients. J Orthop Surg Res 2019;14:103. [PMID: 30975166 DOI: 10.1186/s13018-019-1137-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Zhang N, Meng X, Mei L, Zhao C, Chen W. LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in osteosarcoma through modulating miR-641/HOXA9 signaling pathway. J Cell Biochem 2019. [PMID: 30838699 DOI: 10.1002/jcb.28426] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
18 Zhang B, Zhang Y, Li R, Li J, Lu X, Zhang Y. The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis. J Orthop Surg Res 2020;15:51. [PMID: 32054494 DOI: 10.1186/s13018-020-1576-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
19 Wang X, Zheng H, Shou T, Tang C, Miao K, Wang P. Effectiveness of multi-drug regimen chemotherapy treatment in osteosarcoma patients: a network meta-analysis of randomized controlled trials. J Orthop Surg Res 2017;12:52. [PMID: 28356114 DOI: 10.1186/s13018-017-0544-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
20 Zhang Z, Shao Z, Xiong L, Yang S. Inhibition of autophagy enhances cisplatin-induced apoptosis in the MG63 human osteosarcoma cell line. Oncol Lett 2015;10:2941-6. [PMID: 26722268 DOI: 10.3892/ol.2015.3692] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
21 Yu W, Liu Z, Tang L, Lin F, Yao Y, Shen Z. Efficacy and safety of stereotactic radiosurgery for pulmonary metastases from osteosarcoma: Experience in 73 patients. Sci Rep 2017;7:17480. [PMID: 29234040 DOI: 10.1038/s41598-017-14521-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
22 Ruiz MC, Resasco A, Di Virgilio AL, Ayala M, Cavaco I, Cabrera S, Aleman J, León IE. In vitro and in vivo anticancer effects of two quinoline-platinum(II) complexes on human osteosarcoma models. Cancer Chemother Pharmacol 2019;83:681-92. [PMID: 30661096 DOI: 10.1007/s00280-019-03773-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
23 Mitxelena-Iribarren O, Zabalo J, Arana S, Mujika M. Improved microfluidic platform for simultaneous multiple drug screening towards personalized treatment. Biosens Bioelectron 2019;123:237-43. [PMID: 30224287 DOI: 10.1016/j.bios.2018.09.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
24 Chen Y, Chen H, Xie H, Yuan S, Gao C, Yu L, Bi Z. Non‑covalent proteasome inhibitor PI‑1840 induces apoptosis and autophagy in osteosarcoma cells. Oncol Rep 2019;41:2803-17. [PMID: 30864717 DOI: 10.3892/or.2019.7040] [Reference Citation Analysis]
25 Thorn AP, Daugaard S, Christensen LH, Christensen IJ, Petersen MM. YKL-40 protein in osteosarcoma tumor tissue. APMIS 2016;124:453-61. [PMID: 26988273 DOI: 10.1111/apm.12524] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zhang CL, Zhu KP, Ma XL. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2. Cancer Lett 2017;396:66-75. [PMID: 28323030 DOI: 10.1016/j.canlet.2017.03.018] [Cited by in Crossref: 99] [Cited by in F6Publishing: 101] [Article Influence: 19.8] [Reference Citation Analysis]
27 Cheng A, Zhang Y, Mei H, Fang S, Ji P, Yang J, Yu L, Guo W. Construction of a plasmid for overexpression of human circadian gene period2 and its biological activity in osteosarcoma cells. Tumor Biol 2015;36:3735-43. [DOI: 10.1007/s13277-014-3013-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
28 Liu HC, Zeng J, Zhang B, Liu XQ, Dai M. Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63. J Cell Physiol 2019;234:9358-69. [PMID: 30456894 DOI: 10.1002/jcp.27620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Kun-Peng Z, Xiao-Long M, Chun-Lin Z. LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1. Oncotarget 2017;8:71881-93. [PMID: 29069754 DOI: 10.18632/oncotarget.17985] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 10.4] [Reference Citation Analysis]
30 Cheng DD, Li SJ, Zhu B, Yuan T, Yang QC, Fan CY. Downregulation of BZW2 inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway. Oncol Rep 2017;38:2116-22. [PMID: 28791373 DOI: 10.3892/or.2017.5890] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
31 Ma XL, Zhan TC, Hu JP, Zhang CL, Zhu KP. Doxorubicin-induced novel circRNA_0004674 facilitates osteosarcoma progression and chemoresistance by upregulating MCL1 through miR-142-5p. Cell Death Discov 2021;7:309. [PMID: 34689155 DOI: 10.1038/s41420-021-00694-8] [Reference Citation Analysis]
32 Liang B, Zuo D, Yu K, Cai X, Qiao B, Deng R, Yang J, Chu L, Deng Z, Zheng Y, Zuo G. Multifunctional bone cement for synergistic magnetic hyperthermia ablation and chemotherapy of osteosarcoma. Mater Sci Eng C Mater Biol Appl 2020;108:110460. [PMID: 31923975 DOI: 10.1016/j.msec.2019.110460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 González-fernández Y, Zalacain M, Imbuluzqueta E, Sierrasesumaga L, Patiño-garcía A, Blanco-prieto MJ. Lipid nanoparticles enhance the efficacy of chemotherapy in primary and metastatic human osteosarcoma cells. Journal of Drug Delivery Science and Technology 2015;30:435-42. [DOI: 10.1016/j.jddst.2015.08.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
34 Xu S, Yu X, Xu M, Fu Z, Chen Y, Sun Y, Su Q. Limb function and quality of life after various reconstruction methods according to tumor location following resection of osteosarcoma in distal femur. BMC Musculoskelet Disord 2014;15:453. [PMID: 25539904 DOI: 10.1186/1471-2474-15-453] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
35 Xu WN, Yang RZ, Zheng HL, Jiang LS, Jiang SD. NDUFA4L2 Regulated by HIF-1α Promotes Metastasis and Epithelial-Mesenchymal Transition of Osteosarcoma Cells Through Inhibiting ROS Production. Front Cell Dev Biol 2020;8:515051. [PMID: 33330441 DOI: 10.3389/fcell.2020.515051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]